Showing 431-440 of 2727 results for "".
Are Foreign-Available Sunscreens Really Better?
https://modernaesthetics.com/topics/skincare/foreign-available-sunscreens-really-better/35292/The use of topical sunscreens dates back to the time of ancient Egyptians, who used aloe vera, olive and lotus oil, inorganic clays, rice bran extracts, and mineral powders as photoprotectants. As dermatologists, a lot of us have been purchasing our sunscreens from abroad for years now, and our patiWhere Are We in 2023? A Q&A on Botulinum Toxins
https://modernaesthetics.com/ma-issues-index/2023-nov-dec/where-are-we-in-2023-a-qa-on-botulinum-toxins/35332/Sue Ellen Cox, MD, describes what she is seeing in the evolving neuromodulators landscapeAdding New Services to Your Practice: A Practical Guide
https://modernaesthetics.com/ma-issues-index/2023-july-aug/adding-new-services-to-your-practice-a-practical-guide/35299/Practicing in an ever-advancing industry is exciting and stimulating for healthcare professionals eager to learn more. Owning your own practice requires you to acquire new skills to be able to offer the most cutting-edge services and provide desired results for patients.Revelle Aesthetic’s Avéli
https://modernaesthetics.com/ma-issues-index/2023-july-aug/revelle-aesthetics-aveli/35291/In each issue, Modern Aesthetics® spotlights a new device that cosmetic physicians are introducing to their patients. Here, Arash Akhavan, MD, a New York City-based dermatologist, discusses Revelle Aesthetic’s Avéli, the latest cellulite treatment.Sciton’s Joule X Platform
https://modernaesthetics.com/ma-issues-index/2020-jan-feb/scitons-joule-x-platform/34856/In each issue, Modern Aesthetics® magazine asks top cosmetic physicians about the devices that they are introducing to their patients. Here, Arisa Ortiz, MD, an Assistant Clinical Professor of Dermatology and Director of Laser and Cosmetic Dermatology at UC San Diego, shares her experience with Scit2023 Rewind
https://modernaesthetics.com/ma-issues-index/2023-nov-dec/2023-rewind/35322/2023 was a year that will live in infamy both in the cosmetic bubble and in the world at large, according to Steve Dayan, MD.Qwo from Endo Aesthetics
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/qwo-from-endo-aesthetics/34964/Deanne Mraz Robinson, MD, President and Co-Founder of Modern Dermatology in Westport, CT and an Assistant Clinical Professor of Dermatology at Yale New Haven Hospital, gives us a sneak peek of Endo Aesthetics’ Qwo, the first FDA-approved injectable for the treatment of cellulite in adult women, whicShould You Hire a Scribe?
https://modernaesthetics.com/ma-issues-index/2023-may-june/should-you-hire-a-scribe-1/35280/What to consider before bringing a scribe into your practice and the benefits of doing so.“Best in Show”
https://modernaesthetics.com/ma-issues-index/2023-may-june/best-in-show-1/35270/In each issue, Modern Aesthetics® magazine asks top cosmetic doctors about the newest cosmeceuticals they are offering to patients. Here, Natalie M. Curcio, MD, MPH, a dermatologist and the CEO & Founder of Curcio Dermatology, PC in Nashville, TN, weighs in on Elevai empower and Elevai enfinity,Coming & Going: March/April 2023
https://modernaesthetics.com/topics/skincare/coming-going-marchapril-2023/35268/Everyone is taking Ozempic/Wegovy (semaglutide, Novo Nordisk) or Mounjaro (tirzepatide, Lilly) for weight loss–many of whom may need to lose weight, rein in their diabetes, or both.